A client at 20 weeks gestation reports discomfort after amniocentesis procedure to the nurse. Which of the following assessment findings warrants priority action by the nurse?

Explanation:

A. An excessive amount of amniotic fluid is present.

Polyhydramnios is defined as an excessive accumulation of amniotic fluid within the amniotic sac surrounding the fetus. This condition can occur due to various factors, including fetal abnormalities, maternal health conditions such as diabetes or gestational diabetes, multiple gestations (twins, triplets, etc.), or idiopathic causes where no specific underlying condition is identified. The increased volume of amniotic fluid can be detected through ultrasound examinations, where amniotic fluid index (AFI) measurements are taken to assess the quantity of fluid present. Polyhydramnios is typically diagnosed when the AFI exceeds a certain threshold.

B. The client is carrying more than one fetus.

While it's true that multiple gestations, such as twins or triplets, can sometimes lead to polyhydramnios, the presence of polyhydramnios does not automatically indicate a multiple pregnancy. Polyhydramnios can occur in singleton pregnancies as well, particularly due to other factors like fetal anomalies, maternal health issues, or idiopathic reasons.

C. The fetus is likely to have a congenital anomaly, be growth-restricted, or demonstrate fetal distress during labor.

Polyhydramnios can be associated with various fetal and maternal conditions, but it does not directly indicate specific fetal issues like congenital anomalies, growth restriction, or fetal distress during labor. However, polyhydramnios can sometimes coexist with these conditions or be a result of them. For example, certain fetal abnormalities, such as gastrointestinal obstructions, can lead to polyhydramnios due to impaired swallowing and absorption of amniotic fluid.

D. There is an elevated level of alpha-fetoprotein (AFP) in the amniotic fluid.

Elevated levels of alpha-fetoprotein (AFP) in the amniotic fluid are typically associated with neural tube defects (such as spina bifida) or abdominal wall defects (like gastroschisis or omphalocele) in the fetus. However, AFP levels are not directly related to the presence of polyhydramnios. AFP testing is usually done separately as part of prenatal screening tests to assess the risk of certain fetal abnormalities.

Explanation:

A. Drowsiness: Mild drowsiness is a common side effect of magnesium sulfate therapy and is not necessarily indicative of toxicity. However, severe drowsiness or lethargy can be a sign of magnesium toxicity and should be reported to the provider.

B. Facial flushing: Facial flushing is a common side effect of magnesium sulfate administration and is generally not a sign of toxicity. It is often accompanied by warmth and redness of the skin but is not considered a serious adverse reaction.

C. Nausea: Nausea is another common side effect of magnesium sulfate therapy and is usually mild and transient. It is not typically indicative of toxicity unless it is severe and persistent.

D. Respiratory depression: Respiratory depression is a critical sign of magnesium toxicity. Excessive levels of magnesium can affect neuromuscular function, leading to respiratory muscle weakness and depression. This can result in shallow or slowed breathing, decreased oxygenation, and potential respiratory failure. Respiratory depression is a serious complication that requires immediate intervention, and the nurse should report it to the provider promptly.